Researchers from our group have previously studied the roles of both IGF-2 and IGFBP-7 in schizophrenia [32], as well as in the extinction of fear memories in mouse models [66,67] and as possible targets for treatment in Alzheimer’s disease [68]. The gene discussed is IGF2; the disease is early-onset autosomal dominant Alzheimer disease.